Journal Mobile Options
Table of Contents
Vol. 34, No. 2-3, 2012
Issue release date: September 2012
Section title: Paper
Free Access
Dev Neurosci 2012;34:159–173
(DOI:10.1159/000337984)

Preweaning Sensorimotor Deficits and Adolescent Hypersociability in Grin1 Knockdown Mice

Moy S.S.a, b · Nikolova V.D.a · Riddick N.V.a · Baker L.K.a, b · Koller B.H.b, c
aDepartment of Psychiatry, bCarolina Institute for Developmental Disabilities, cDepartment of Genetics, University of North Carolina School of Medicine, Chapel Hill, N.C., USA
email Corresponding Author

Abstract

Mice with knockdown of the N-methyl-d-aspartate (NMDA) receptor NR1 subunit, encoded by the gene Grin1, have been investigated as a model for the intrinsic NMDA hypofunction hypothesized for schizophrenia. Previous work has shown that adult Grin1 mutant mice have overt deficits in habituation and sensorimotor gating, exaggerated reactivity to environmental stimuli, reduced social approach, and other alterations that reflect behavioral manifestations of schizophrenia. In humans, the emergence of overt symptoms of the disorder typically occurs in adolescence or early adulthood, suggesting a role for aberrant maturation of NMDA receptor signaling in symptom onset. The following study evaluated Grin1 mutant mice for abnormal behavioral phenotypes during the preweaning, adolescent, and adult periods. Measures included open field activity, prepulse inhibition of acoustic startle responses, and social preference in a three-chamber choice task. Mice from the C57BL/6J inbred strain, one of the parental strains for the Grin1 line, were also tested. The results showed that developmental reduction of NMDA receptor function led to significant alterations in behavior during the second and third weeks of life, including exaggerated startle responses and sensorimotor gating deficits on postnatal day 13, and pronounced hypersociability in adolescence. Male Grin1 mutant mice were more susceptible than female mice to the detrimental effects of decreased NMDA signaling. Overall, these findings provide evidence that reduced Grin1 function leads to abnormal phenotypes in the preweaning period, and that deficient NMDA signaling can lead to both overt hypersociability or marked asociality, dependent upon sex and age.

© 2012 S. Karger AG, Basel


  

Key Words

  • Hyperactivity
  • Impulsive behavior
  • NMDA receptor
  • Postnatal period
  • Prepulse inhibition
  • Schizophrenia
  • Social approach
  • Startle

 Introduction

Antagonists of the N-methyl-d-aspartate (NMDA) receptor, such as ketamine and phencyclidine, can induce a schizophrenia-like syndrome in adults, suggesting that disruption of NMDA receptor signaling could play a role in symptoms of schizophrenia [1,2,3,4,5]. The psychotomimetic effects of ketamine, a dissociative anesthetic, appear to be age-dependent. A substantial percentage of adults over the age of 30 show adverse emergence reactions following ketamine anesthesia, while children and adolescents have a much lower incidence of detrimental psychological effects [6]. Interestingly, symptoms of schizophrenia typically emerge in late adolescence and early adulthood [7], the time points of increasing susceptibility to ketamine effects, implicating aberrant maturation of neurocircuitry involving NMDA receptor signaling in onset of the disorder [5].

Mice with reduced levels of the obligatory NR1 subunit (Grin1) of the NMDA receptor have been proposed as an animal model for intrinsic NMDA hypofunction [8,9,10,11]. These mice show profound changes in behavior that parallel symptoms in schizophrenia, including deficits in prepulse inhibition of acoustic startle responses and reduced social approach [8,9,10,11,12,13]. Grin1 knockdown mice also have altered exploration in novel environments, exaggerated startle responses, and perseverative overgrooming [8,9,10,12,14]. Further, in a resident-intruder assay for social interaction and aggression, the Grin1 mutant mice show significantly blunted neuronal activation across several brain regions, including cingulate cortex, amygdala, and the dentate gyrus of the hippocampal formation [15].

Although these studies have clearly established aberrant behavioral profiles in adult mice with reduced Grin1 expression, a remaining question is whether the onset of phenotypic changes has a developmental time course that reflects the typical emergence of symptoms in schizophrenia. A recent intriguing report by Ramsey et al. [16] showed that Grin1 knockdown mice have significant decreases in striatal spine density, a marker for synapse number, during the adolescent period [postnatal day (PD) 40], but not on PD14, providing evidence for detrimental effects of abnormal maturation of NMDA receptor signaling. There is additional evidence from other mouse models that the postweaning stage in mice (PD24–28) could be a sensitive period for disruption of sensorimotor gating. Nakamura et al. [17], using a panel of inbred mouse strains, investigated the role of tryptophan hydroxylase in the maturation of prepulse inhibition. The researchers found that intact serotonergic function was critical for the development of prepulse inhibition during the postweaning period, but not the preweaning period. Similarly, the emergence of abnormal startle reactivity in Fmr1-null mice, a model of fragile X syndrome, does not occur until the third or fourth postnatal week [18].

The focus of the present studies was to determine whether aberrant behavioral phenotypes were present in preweaning or adolescent Grin1 mice, which could be informative for maturational events in NMDA receptor signaling relevant to schizophrenia onset, or for the more subtle prodromal changes evident before first episodes of the disorder. We conducted the startle test at PD13, when startle responses to acoustic stimuli are often first evident in mouse pups, and again at PD17, when significant maturation of the auditory system has occurred [17,18,19,20,21]. Open-field tests were conducted at PD12 and PD18–20, to encompass a period when mouse pups show rapid development of locomotor abilities [22]. Social approach was examined on PD34–38, in periadolescence, before the postpuberty period of late adolescence and young adulthood that, in humans, is associated with increased vulnerability to schizophrenia [7]. Finally, the open field and social approach tests were conducted in a separate set of adult animals, to confirm previous findings of abnormal exploration and deficient sociability in Grin1 mutant mice [8,9,10,23].

 Methods


 Subjects

NR1-NMDA receptor subunit (Grin1) knockdown mice and littermate controls served as subjects. The mutant mice were engineered by incorporating a neomycin resistance gene (neo) into intron 20 of the Grin1 locus, leading to an underexpression, but not elimination, of the Grin1 gene [10]. The Grin1+/+, Grin1+/neo, and Grin1neo/neo subjects for the present studies were generated from heterozygous breeder pairs. Briefly, offspring were F1 hybrid mice, obtained by the intercross of 129S6 (Taconic)-Grin1+/neo female mice with C57BL/6-Grin1+/neo males. The 129-Grin1+/neo mice were coisogenic for the Grin1neo mutation. The C57BL/6-Grin1+/neo mice were derived from 12 generations of backcrossing to C57BL/6J (Jackson Laboratories, Bar Harbor, Me., USA). Subjects tested during the preweaning and adolescent periods were taken from 10 litters, while subjects tested in adulthood were taken from 20 litters. In addition, subjects included offspring of 4 litters from C57BL/6J (B6) breeding stock (Jackson Laboratory). The B6 group was evaluated to provide a profile of behavior in one of the parental strains of the Grin1 line (and not as a direct comparison group for statistical analyses). For all litters, the day of birth was considered PD0.

Animals were maintained on a 12-hour light:12-hour dark circadian schedule with lights on at 7 a.m., in a 20–24°C housing room, and provided water and mouse chow ad libitum. A small section of PVC pipe was present in each cage for enrichment, and dams were provided cotton nestlets for nesting material. All breeding and testing procedures were conducted in strict compliance with the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, National Research Council, 1996) and approved by the Institutional Animal Care and Use Committee of the University of North Carolina.

 Study Design

One set of mice was tested for exploration in a novel environment and sensorimotor gating during the preweaning period, and social approach in adolescence. All pups were given two tests in the open field, one on PD12 and one on PD18–20, and two tests for acoustic startle responses, one on PD13 and one on PD17. The three-chamber social choice test was conducted on PD34–38. Numbers of mice were 15 Grin1+/+, 25 Grin1+/neo, 15 Grin1neo/neo, and 23 B6 offspring. A separate set of adult mice (21 Grin1+/+ and 21 Grin1neo/neo) were tested in the open field and social approach assays at the age of 3–6 months, with 18–24 days between the two procedures. For all groups, both male and female mice were evaluated, with a range of 6–16 of each sex per group.

 Open-Field Test in Preweaning Mice

On PD12 and again on PD18–20, the litter was removed from the home cage and placed into a beaker. One at a time, each pup was placed into the center of a Phenotyper box (30.5 × 30.5 × 43.5 cm; Noldus Information Technology, Wageningen, The Netherlands). The mouse was allowed to acclimate to the apparatus for 30 s and then freely explore for 10 min, before being returned to a separate beaker. When all pups had been tested, the litter was returned to the home cage. The integrated camera system in the Phenotyper was connected to a computer and the video was scored for distance traveled (cm) in real time using Ethovision tracking software (Noldus Information Technology). In addition, the experimenter viewed the trial in real time and recorded the number of rearing movements. The Phenotyper box was wiped down with water and dried with a paper towel after every trial, and cleaned with 70% ethanol at the end of each testing day.

 Open-Field Test in Adult Mice

Exploratory activity in a novel environment was assessed for 1 h in a photocell-equipped automated open field (41 × 41 × 30 cm height; Versamax system, Accuscan Instruments). Measures were taken of total distance traveled and time spent in the center during the test. Activity chambers were contained inside sound-attenuating boxes, equipped with houselights and fans. Removable floors were washed with hot soapy water between each trial. Chamber walls were wiped down with water and dried with a paper towel after every trial, and cleaned with 70% ethanol at the end of each testing day.

 Acoustic Startle Procedure

The acoustic startle assay was based on the reflexive whole-body flinch, or startle response, following exposure to a sudden noise. Animals were tested with a San Diego Instruments SR-Lab system, using published procedures [24,25]. Briefly, mice were placed in a small Plexiglas cylinder within a larger, sound-attenuating chamber (San Diego Instruments). The cylinder was seated upon a piezoelectric transducer, which allowed vibrations to be quantified and displayed on a computer. Sensitivity calibration of the transducer was constant between PD13 and PD17 (i.e. sensitivity was not increased to accommodate smaller pup sizes). The chamber included a houselight, fan, and a loudspeaker for the acoustic stimuli (bursts of white noise). Background sound levels (70 dB) and calibration of the acoustic stimuli were confirmed with a digital sound level meter (San Diego Instruments).

Each test session consisted of 42 trials, presented following a 5-min habituation period. There were 7 different types of trials: the no-stimulus trials, trials with the acoustic startle stimulus (40 ms; 120 dB) alone, and trials in which a prepulse stimulus (20 ms; either 74, 78, 82, 86, or 90 dB) had onset 100 ms before the onset of the startle stimulus. The different trial types were presented in blocks of 7, in randomized order within each block, with an average intertrial interval of 15 s (range: 10–20 s). Measures were taken of the startle amplitude for each trial, defined as the peak response during a 65-ms sampling window that began with the onset of the startle stimulus. Levels of prepulse inhibition at each prepulse sound level were calculated as 100 – [(response amplitude for prepulse stimulus and startle stimulus together / response amplitude for startle stimulus alone) × 100].

 Three-Chamber Social Choice Test

Mice were tested in an automated three-chamber box, using methods developed by our laboratory [26,27,28]. Dividing walls had retractable doorways allowing access into each chamber. The automated box had photocells embedded in each doorway to allow quantification of entries and duration in each chamber of the social test box. The chambers of the apparatus were cleaned with water and dried with paper towels between each trial. At the end of each test day, the apparatus was sprayed with 70% ethanol and wiped clean with paper towels.

The choice test had three 10-min phases:

(1) Habituation: The test mouse was first placed in the middle chamber and allowed to explore, with the doorways into the two side chambers open.

(2) Sociability: After the habituation period, the test mouse was enclosed in the center compartment of the social test box, and an unfamiliar mouse (stranger 1; a sex-matched C57BL/6J adult) was enclosed in a wire cage (11 cm H, 10.5 bottom diameter, bars spaced 1 cm apart; Galaxy Cup, Spectrum Diversified Designs, Inc., Streetsboro, Ohio, USA) and placed in a side chamber. All stranger mice had been previously habituated to the wire cage across at least 5 days. The location for stranger 1 alternated between the left and right sides of the social test box across subjects. An empty wire cage was placed in the opposite side, to serve as a novel object control. Following placement of stranger 1, the doors were reopened, and the subject was allowed to explore the entire social test box. Measures were taken of the amount of time spent in each chamber and the number of entries into each chamber by the automated testing system. In addition, the amount of time spent sniffing each of the wire cages was recorded by a human observer.

(3) Preference for social novelty: At the end of the sociability test, each mouse was further tested for preference to spend time with a more novel stranger. A new unfamiliar mouse (stranger 2; a sex-matched C57BL/6J adult from a home cage different from that of stranger 1) was placed in the wire cage that had been empty during the previous session. The test mouse then had a choice between the first, already investigated mouse (stranger 1) and the novel unfamiliar mouse (stranger 2). The same measures were taken as with the sociability test.

 Statistics

Statview (SAS Inc., Cary, N.C., USA) was used for data analyses. Two-way or repeated-measures analysis of variance (ANOVA) were used to determine effects of genotype (wild type, heterozygous, or Grin1 knockdown) and sex. Separate analyses for males and females were then conducted, in order to determine the effects of genotype within each sex. Post hoc comparisons were conducted with Fisher’s protected least significant difference tests following significant effects in the overall ANOVAs. Within-group repeated-measures ANOVAs were used to determine side preferences in the social approach assay. Data from the separate set of C57BL/6J mice were not included in the analyses with the Grin1 mice. For all comparisons, significance was set at p < 0.05.

 Results


 Body Weight (PD12, 17, 34–38)

Differences in body weight were observed in the male groups, starting at PD17 (fig. 1a). The male Grin1neo/neo mice were smaller than both the wild-type and heterozygous males at both PD17 and PD34–38 [post hoc tests following main effect of genotype, F(2, 29) = 8.03, p = 0.0017; genotype × time interaction, F(4, 58) = 3.77, p = 0.0086]. These significant differences were not found in the female Grin1 groups (fig. 1b). In the C57BL/6J mice (fig. 1c), the male mice weighed significantly more than the female mice by the adolescent period [post hoc tests following main effect of sex, F(1, 21) = 9.37, p = 0.0059; sex × time interaction, F(2, 42) = 57.8, p < 0.0001].

FIG01
Fig. 1. Body weight and growth. Data shown are means ± SEM. Numbers of mice tested were 15 Grin1+/+ (9 males and 6 females), 25 Grin1+/neo (16 males and 9 females), 15 Grin1neo/neo (8 males and 7 females), and 23 B6 offspring (13 males and 10 females). ** p < 0.05, comparison to both wild-type and heterozygous mice. * p < 0.05, comparison to female mice.

 Open-Field Test (PD12 and 18–20)

Distance Traveled. As previously observed in adult Grin1neo/neo mice [8,10,23], the loss of NMDA function led to overt increases in locomotor activity (fig. 2). Two-way ANOVAs confirmed significant main effects of genotype on PD12 [F(2, 49) = 14.31, p < 0.0001] and PD18–20 [F(2, 49) = 66.16, p < 0.0001]. Separate analyses for the male and female mice revealed that significant differences were only observed in the male Grin1 mice on PD12 [F(2, 30) = 16.77, p < 0.0001], but were seen in both male and female mice on PD18–20 [males, F(2, 30) = 98.22, p < 0.0001; females, F(2, 19) = 13.48, p = 0.0002]. The male and female C57BL/6J mouse pups tested at the same ages traveled a similar distance in the open field. Overall, there were no significant main effects or interactions for sex in the measures from the open-field test.

FIG02
Fig. 2. Increased distance traveled by preweaning Grin1neo/neo mice in an open field. Data shown are means ± SEM for a 10-min test. Scales a and b are different, to accommodate changes across age. ** p < 0.05, comparison to both wild-type and heterozygous mice.

Time in Center Regions. In addition to increased ambulation, the Grin1neo/neo mice also spent more time in the center of the open field, an indication of decreased anxiety-like behavior (fig. 3). Significant main effects of genotype were evident on PD12 [F(2, 49) = 10.17, p = 0.0002] and PD18–20 [F(2, 49) = 7.54, p = 0.0014]. Although the amount of time spent in the center by the Grin1neo/neo mice was higher, dependent on sex and age, than time spent by the wild-type and heterozygous groups, it is notable that the levels were comparable to the highly exploratory C57BL/6J mice.

FIG03
Fig. 3. Increased time in the center regions of an open field in preweaning Grin1neo/neo mice. Data shown are means ± SEM for a 10-min test. ** p < 0.05, comparison to both wild-type and heterozygous mice.

 Open-Field Test in Adult Mice

A separate set of mice (age 3–6 months) were tested in a larger open field than used with the preweaning groups. During the first intervals of the 1-hour test, the wild-type and mutant mice had similar levels of locomotion (fig. 4). However, the Grin1neo/neo group failed to demonstrate a typical pattern of habituation [main effect of genotype, F(1, 37) = 8.71, p = 0.0055; genotype × time interaction, F(11, 407) = 4.54, p < 0.0001]. The Grin1 knockdown mice also had small, albeit significant, increases in time spent in the center region [main effect of genotype, F(1, 37) = 8.21, p = 0.0068; data not shown]. The repeated-measures ANOVAs did not indicate any significant main effects or interactions for sex in the measures from the open-field test.

FIG04
Fig. 4. Habituation deficits in adult Grin1neo/neo mice in an open field. Data shown are means ± SEM for a 1-hour test. Numbers of mice were 21 Grin1+/+ (15 males and 6 females) and 21 Grin1neo/neo (10 males and 11 females). Data from one Grin1neo/neo male were lost when the mouse escaped from the open field. * p < 0.05.

 Acoustic Startle Test (PD13 and 17)

Startle Response Amplitude.Previous studies have found markedly exaggerated startle responses in adult Grin1neo/neo mice [8,12,13]. This same enhancement of startle was evident in both male and female mutant groups during the preweaning period (fig. 5). Repeated-measures ANOVAs for startle amplitudes indicated highly significant main effects of genotype [PD13; F(2, 49) = 21.28, p < 0.0001; PD17; F(2, 49) = 17.78, p < 0.0001] and genotype × decibel level interactions [PD13; F(12, 294) = 7.39, p < 0.0001; PD17; F(12, 294) = 8.4, p < 0.0001]. Overall, there were no significant main effects or interactions for sex on startle amplitudes. In the C57BL/6J group, male and female mice showed similar levels of startle amplitude, with marked increases from PD13 to PD17 (data not shown).

FIG05
Fig. 5. Exaggerated startle responses following presentation of acoustic stimuli in Grin1neo/neo mice. Data shown are means ± SEM for each group. Scales for a and b are different from c and d, to accommodate increased startle amplitude across age. Trials included no stimulus (NoS) trials and acoustic startle stimulus (AS) alone trials. * p < 0.05, comparison to heterozygous mice. ** p < 0.05, comparison to both wild-type and heterozygous mice.

Prepulse Inhibition of Startle Responses. During adulthood, both male and female Grin1neo/neo mice have impaired prepulse inhibition [29]. However, in the present study, only the male mutant mice demonstrated the characteristic deficits, and the reductions appeared more severe on PD17, in contrast to the earlier age (fig. 6). The milder phenotype on PD13 was reflected in the lack of a genotype main effect in the overall repeated-measures ANOVA [main genotype effect, F(2, 49) = 1.54, p = 0.2248; genotype × decibel level interaction, F(8, 196) = 2.95, p = 0.0039]. However, a strong main effect of genotype was evident 4 days later, on PD17 [F(2, 49) = 7.38, p = 0.0016], as well as a genotype × decibel level interaction [F(8, 196) = 2.26, p = 0.0246]. There was also a significant main effect of sex on PD17 [F(1, 49) = 4.06, p = 0.0495], in line with the lack of prepulse inhibition deficits in the female Grin1neo/neo mice.

FIG06
Fig. 6. Reduced prepulse inhibition in male, but not female, Grin1neo/neo mice. Data shown are means ± SEM for each group. ** p < 0.05, comparison to both wild-type and heterozygous mice.

As found with the measure for startle amplitude, there were no significant main effects or interactions for sex on percent inhibition in the C57BL/6J groups (data not shown).

 Social Approach (PD34–38)

Time Spent in Each Side of the Three-Chamber Test Box. Overt deficits in social approach and interaction have been reported for adult Grin1neo/neo mice [8,9,10]. However, in the present study, the male mutant mice demonstrated a striking and unexpected enhancement of sociability (fig. 7). An overall repeated-measures ANOVA confirmed a significant interaction between genotype and side of the test box [F(2, 49) = 5.39, p = 0.0077]. Within-group comparisons indicated that only the Grin1neo/neo males had a significant preference for spending time in the proximity of a stranger mouse, versus an empty cage.

FIG07
Fig. 7. Time spent in each of the side chambers during the test for sociability (a, b) and social novelty (c, d). Data shown are mean ± SEM for each group for a 10-min test. * p < 0.05, within-group comparison between stranger 1 side and opposite side. ## p < 0.05, comparison to both wild-type and heterozygous mice.

In the subsequent test for social novelty, each mouse was given a choice between spending time in the side with the first stranger mouse, versus a newly introduced second stranger. Although the repeated-measures analyses did not reveal any genotype effects during this phase of the social approach test, the Grin1neo/neo males were the only group to demonstrate a significant preference for the more novel conspecific. Thus, the mutant males not only showed a general increase in social interest, but also recognized and preferred a less familiar stranger.

Time Spent Sniffing Each Cage. The measure for sniffing provides a more specific index of attention directed toward the social targets in the approach test [27,28,30]. In the present study, the results supported an aberrant hypersociability in the adolescent Grin1neo/neo males (fig. 8). Again, the Grin1neo/neo males had a significantly enhanced approach to the stranger mouse [main effect of genotype, F(2, 49) = 3.64, p = 0.0335; genotype × side interaction, F(2, 49) = 9.89, p = 0.0002]. The main effect of sex approached significance [F(1, 49) = 3.92, p = 0.0533], reflecting the lower levels of sniffing observed in the female mice.

FIG08
Fig. 8. Time spent sniffing each of the side chambers during the test for sociability (a, b) and social novelty (c, d). Data shown are mean ± SEM for each group for a 10-min test. * p < 0.05, within-group comparison between stranger 1 side and opposite side. ## p < 0.05, comparison to both wild-type and heterozygous mice. p values above bars indicate nonsignificant trends for within-group sociability.

In the test for social novelty preference, significant effects of genotype were evident in both male and female mice, confirming the results from the overall repeated-measures ANOVA [main effect of genotype, F(2, 48) = 23.4, p < 0.0001]. However, the two sexes showed different patterns: the male Grin1neo/neo mice again exhibited enhanced preference for the more novel stranger, while the female Grin1neo/neo mice had general increases in sniffing directed towards both cages [main effect of sex, F(1, 48) = 16.43, p = 0.0002; sex × side interaction, F(1, 48) = 5.45, p = 0.0237].

Entries into Each Side of the Three-Chamber Test Box. Both the male and female NMDA receptor mutant mice had similar significant increases in number of entries into each side of the test box, indicating that the differential profiles for social preference were not dependent upon differential levels of exploration or activity during the test (fig. 9). The overall repeated-measures ANOVAs revealed significant main effects of genotype for both the sociability test [F(2, 49) = 24.47, p < 0.0001] and the preference for social novelty test (data not shown) [F(2, 49) = 10.02, p = 0.0002]. There were no main effects or interactions for the variables sex or side of chamber for the entries measures.

FIG09
Fig. 9. Entries into each of the side chambers during the test for sociability. Data shown are mean ± SEM for each group for a 10-min test. ## p < 0.05, comparison to both wild-type and heterozygous mice.

Social Approach in Adolescent C57BL/6J Mice. As shown in figure 10, the C57BL/6J mice showed mild sociability with the measures of time in each side [within-group comparisons following significant effect of side, F(1, 21) = 7.85, p = 0.0107] and time spent sniffing each cage [within-group comparisons following significant effect of side, F(1, 21) = 36.77, p < 0.0001]. When the second stranger was introduced to the social test box, the adolescent mice showed a shift toward the more novel conspecific [time in each side, effect of side, F(1, 21) = 9.3, p = 0.0061; time spent sniffing each cage, F(1, 21) = 21.85, p = 0.0001]. Although the within-group comparisons were not consistently significant in both male and female mice, the overall ANOVAs did not reveal any effects of sex on social approach in the C57BL/6J mice. As observed with the Grin1 groups, no side preferences were evident with the measure for entries.

FIG10
Fig. 10. Social approach in C57BL/6J mice on PD34–38. Data shown are mean ± SEM for each group for a 10-min test. * p < 0.05, within-group comparison between stranger 1 side and opposite side.

 Social Approach in Adult Mice

In confirmation of previous findings, adult Grin1neo/neo mice (3–6 months in age) had significant decreases in social preference (fig. 11). During the test for sociability, significant main effects of genotype were found for the measure of time spent in each side [F(1, 38) = 14.41, p = 0.0005] and time spent sniffing each cage [F(1, 38) = 15.99, p = 0.0003; genotype × side interaction, F(1, 38) = 4.42, p = 0.0422]. Post hoc analyses indicated that both male and female Grin1 knockdown mice spent less time in the proximity of the stranger mouse, in comparison to the wild-type mice. In contrast to findings from the open field, the Grin1neo/neo mice had reduced exploration in the social approach task, measured by entries into each side [main genotype effect, F(1, 38) = 11.22, p = 0.0018; genotype × side interaction, F(1, 38) = 5.98, p = 0.0095]. Thus, the adult Grin1neo/neo mice did not demonstrate the hypersociability or increased exploration observed in the adolescent mutant mice.

FIG11
Fig. 11. Social approach deficits in adult Grin1neo/neo mice. Data shown are mean ± SEM. * p < 0.05, within-group comparison between stranger 1 side and empty cage side. # p < 0.05, comparison to Grin1+/+ mice.

In the test for social novelty preference, neither the male nor female groups showed significant preference for the more novel stranger 2, versus the previously investigated stranger 1 (data not shown). Although the test did not reveal any deficiencies in discrimination, the Grin1 knockdown mice had general decreases in time spent in the side chambers [main genotype effect [,] F(1, 38) = 7.16, p = 0.0109], time spent sniffing the two stranger cages [main genotype effect [,] F(1, 38) = 5.35, p = 0.0263], and entries during the test [main genotype effect, F(1, 38) = 5.77, p = 0.0213].

 Discussion

The first episode of schizophrenia typically occurs during late adolescence or early adulthood [7]. Olney and Farber [5] proposed the time of onset for the disorder is linked to maturation of neural circuitry that is dependent upon intact NMDA receptor function. However, the present study found that abnormal behavioral phenotypes were clearly evident on PD12 and 13 in mice with reduced expression of Grin1. Preweaning male and female Grin1 mutant pups exhibited hyperactivity in an open field and marked exaggeration of acoustic startle responses, similar to Grin1neo/neo adults. The male Grin1neo/neo mice had mild impairment of prepulse inhibition at PD13, and more overt impairment by PD17. Further, the Grin1neo/neo males also had overt hypersociability in adolescence, in contrast to the deficits in social approach observed in adult mutant mice in the present study, and in previous reports [8,9,10].

In humans, the startle reflex can be elicited in newborn infants [31]. However, prepulse inhibition may be reduced or absent in neonates, indicating that further maturation of brain structures is necessary to obtain levels of sensorimotor gating found in school age children and adults [32,33,34]. Similarly, startle responses to an acoustic stimulus can be found in mice at the time of ear opening (PD12–13) [20], while the time course for maturation of prepulse inhibition can extend beyond the postweaning period [17]. The present study found a marked increase in the magnitude of startle responses across days PD13–17 in C57BL/6J mice, without overt changes in prepulse inhibition, except at the lowest prepulse sound level. Aberrant acoustic startle responses and prepulse inhibition could be observed by PD13 in the male Grin1neo/neo mice. These alterations were exacerbated by PD17, suggesting that neural development was further disrupted by the NMDA receptor hypofunction across the 4-day span. Only the male Grin1neo/neo mice demonstrated significant deficits in prepulse inhibition, although a previous study found similar decreases in prepulse inhibition in adult male and female Grin1neo/neo mice [29]. Overall, male mutant mice had a more severe phenotype than the females for most measures. These findings are in line with results from epidemiological studies on schizophrenia prevalence rates, which suggest that males have an earlier onset of psychosis and a more severe symptomatology [35,36,37].

Previous studies have reported marked social approach deficits in adult Grin1neo/neo mice [8,9,10], as well as mice with decreased NMDA receptor glycine affinity (Grin1D481N mice) [38]. Therefore, we were surprised to find enhanced sociability in the mutant mice during the adolescent period. It is possible that an aberrant increase in social approach indicates a lack of normal inhibitory processes governing interaction with unfamiliar and potentially dangerous adult mice. Similar to the findings from the open-field test, in which the Grin1neo/neo preweaning mice spent more time in the center region, the hypersociability could be an index for deficient environmental constraints on responses, reminiscent of inappropriate and impulsive behavior. Halene et al. [9] also found reduced behavioral inhibition in adult Grin1neo/neo mice tested in a novel open field and zero maze, but in their study, the mutant mice had significantly decreased sociability in a three-chamber choice task.

Altered signaling by the schizophrenia candidate gene Neuregulin 1(Nrg1) has been implicated in the reduced NMDA receptor function proposed for schizophrenia [39]. We have found that adult male mice with reduced expression of Nrg1, or the Nrg1 receptors, Erbb3 and Erbb4, have significant hypersociability in the three-chamber task [40]. The increased social approach was not accompanied by other behavioral changes observed in the adolescent Grin1neo/neo mice, including enhanced preference for social novelty or increased entries during the task. Abnormal increases in sociability have also been reported for mice with deletion of Dlg4 (PSD-95), a model for dysfunction of excitatory synapses relevant to autism and other neurodevelopmental disorders [41]. Mice with reduced MeCP2, a model for Rett syndrome, can show hypersociability in both adolescence (PD32–34) [42] and adulthood (12–13 weeks of age) [43]. A recent study reported that age-dependent alterations in cortical NMDA receptor density could be found in both postmortem samples from Rett syndrome subjects, and in the MeCP2-null mouse model [44]. Thus, alterations in several genes linked to NMDA receptor function result in a hypersociability phenotype, similar to the increased social approach we observed in the male Grin1neo/neo mice.

One goal for the present study was to determine age-dependent vulnerability to disruption of Grin1. Other researchers have investigated critical periods in susceptibility to NMDA receptor hypofunction. Belforte et al. [45] used elegant engineering techniques to selectively disrupt Grin1 in GABAergic neurons during either the postnatal period or postadolescence. The postnatal ablation led to an abnormal behavioral profile starting at 8 weeks of age, including transient hyperlocomotion, decreased center time in an open field, and reduced prepulse inhibition, without concomitant changes in startle amplitudes. These aberrant phenotypes were not observed with the postadolescent ablation, providing evidence that the behavioral effects were dependent upon a developmental dysregulation of NMDA function. As previously noted, Ramsey et al. [16] reported that Grin1neo/neo mice have significant loss of synaptic spine density in the striatum at 6 weeks of age, but not at 2 weeks. The loss of striatal synapses was associated with a 50–80% decrease in synaptic Disc1 (Disrupted-in-Schizophrenia-1) protein in the 6-week-old mice. Notably, the Disc1 depletion was also detected in the neonatal Grin1neo/neo mice, although to a lesser extent (25%) than the adolescent mice. Other research groups have found that mutations in Disc1 can lead to hyperactivity and impaired prepulse inhibition in adult mice [46,47,48], suggesting that reduced Disc1 expression in Grin1neo/neo mice could play a role in abnormal phenotypes.

The maturational events in the preweaning and adolescent periods include high levels of synaptogenesis in multiple brain regions, followed by refinement and pruning of synaptic connections [49]. Disruption of the processes regulating synapse density has been implicated in the developmental pathology of schizophrenia [50,51,52,53]. Given that NMDA receptors have a critical role in dendritic spine motility and density [16,54], NMDA hypofunction could have a profound impact on the maintenance of appropriate synaptic connections. In particular, Hayashi-Takagi et al. [55] have shown that NMDA receptors regulate the ability of Disc1 to stabilize synaptic structural plasticity by binding to Kalirin-7 (Kal-7), which controls a rho family small GTP-binding protein, Rac1, important for dendritic spine morphology and function. Thus, abnormalities in either NMDA receptor function or Disc1 could be a mechanistic basis for aberrant synaptic refinement and pruning, relevant to the emergence and progression of symptoms in schizophrenia [50].

An important caveat for this study is that repeated testing in behavioral assays could be especially stressful for preweaning mice. In particular, repeated maternal separation has been associated with both short-term and long-term negative effects on mouse offspring, including increased anxiety-like and depression-like responses, alterations in social behavior, and learning deficits [56,57,58]. Although some researchers have found that negative outcomes from maternal separation can be nonsignificant or strain-dependent [59,60,61,62], it is possible that Grin1neo/neo mice could have a differential susceptibility to the effects of preweaning stress, in comparison to wild-type mice. Therefore, the hypersociability phenotype in the adolescent mutant mice might be dependent on both genetic and environmental factors, in line with the detrimental interactions between genetic vulnerability and stress proposed for schizophrenia [63,64,65].

The identification of prodromal indicators for the emergence of schizophrenia could be especially important if early intervention can attenuate progression of the disorder [66]. For example, treatment with an antipsychotic compound, beginning at the first psychotic episode, has been shown to prevent the reductions in gray matter volume associated with schizophrenia [67,68]. In this regard, mouse models of developmental onset are valuable screens to determine preclinical efficacy of early treatment [11,69]. The present results suggest that aberrant phenotypes in preweaning and adolescent Grin1neo/neo mice could be used to model premorbid abnormalities that signal increased susceptibility for the onset of schizophrenia [70,71,72].

 Acknowledgments

Support for these studies was contributed by NIMH grant MH080069 and NICHD grant P30 HD03110. We are grateful for the contribution of Leah Jania and Rebecca Dye, who conducted the genotyping assays for the Grin1 mice.


References

  1. Coyle JT: Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 2006;26:365–384.
  2. Jentsch JD, Roth RH: The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999;20:201–225.
  3. Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmuller B: Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 1980;20:379–382.
  4. Moghaddam B: Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:859–870.
  5. Olney JW, Farber NB: Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995;52:998–1007.
  6. Marshall BE, Longnecker DE: General anesthetics; in Gilman AG, Rall TW, Nies AS, Taylor P (eds): Goodman and Gilman’s The Pharmacological Basis of Therapeutics. New York, Pergamon Press, 1990.
  7. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders DSM-IV TR (Text Revision). Arlington, American Psychiatric Association, 2000.
  8. Duncan GE, Moy SS, Perez A, Eddy DM, Zinzow WM, Lieberman JA, Snouwaert JN, Koller BH: Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behav Brain Res 2004;153:507–519.
  9. Halene TB, Ehrlichman RS, Liang Y, Christian EP, Jonak GJ, Gur TL, Blendy JA, Dow HC, Brodkin ES, Schneider F, Gur RC, Siegel SJ: Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia. Genes Brain Behav 2009;8:661–675.
  10. Mohn AR, Gainetdinov RR, Caron MG, Koller BH: Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999;98:427–436.
  11. Ramsey AJ: NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia. Prog Brain Res 2009;179:51–58.
  12. Fradley RL, O’Meara GF, Newman RJ, Andrieux A, Job D, Reynolds DS: STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav Brain Res 2005;163:257–264.
  13. Moy SS, Perez A, Koller BH, Duncan GE: Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function. Brain Res 2006;1089:186–194.
  14. Moy SS, Nadler JJ, Poe MD, Nonneman RJ, Young NB, Koller BH, Crawley JN, Duncan GE, Bodfish JW: Development of a mouse test for repetitive, restricted behaviors: relevance to autism. Behav Brain Res 2008;188:178–194.
  15. Duncan GE, Inada K, Farrington JS, Koller BH, Moy SS: Neural activation deficits in a mouse genetic model of NMDA receptor hypofunction in tests of social aggression and swim stress. Brain Res 2009;1265:186–195.
  16. Ramsey AJ, Milenkovic M, Oliveira AF, Escobedo-Lozoya Y, Seshadri S, Salahpour A, Sawa A, Yasuda R, Caron MG: Impaired NMDA receptor transmission alters striatal synapses and DISC1 protein in an age-dependent manner. Proc Natl Acad Sci USA 2011;108:5795–5800.
  17. Nakamura K, Koyama Y, Takahashi K, Tsurui H, Xiu Y, Ohtsuji M, Lin QS, Sugawara Y, Sawabe K, Ohashi A, Ohnuma T, Arai H, Nishimura H, Hasegawa H, Hirose S: Requirement of tryptophan hydroxylase during development for maturation of sensorimotor gating. J Mol Biol 2006;363:345–354.
  18. Yun SW, Platholi J, Flaherty MS, Fu W, Kottmann AH, Toth M: Fmrp is required for the establishment of the startle response during the critical period of auditory development. Brain Res 2006;1110:159–165.
  19. Bignami G, Alleva E, Chiarotti F, Laviola G: Selective changes in mouse behavioral development after prenatal benzodiazepine exposure: a progress report. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:587–604.
  20. Shnerson A, Willott JF: Ontogeny of the acoustic startle response in C57BL/6J mouse pups. J Comp Physiol Psychol 1980;94:36–40.
  21. Tremml P, Lipp HP, Muller U, Ricceri L, Wolfer DP: Neurobehavioral development, adult openfield exploration and swimming navigation learning in mice with a modified beta-amyloid precursor protein gene. Behav Brain Res 1998;95:65–76.
  22. Ryan BC, Young NB, Crawley JN, Bodfish JW, Moy SS: Social deficits, stereotypy and early emergence of repetitive behavior in the C58/J inbred mouse strain. Behav Brain Res 2010;208:178–188.
  23. Duncan GE, Moy SS, Lieberman JA, Koller BH: Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction. Pharmacol Biochem Behav 2006;85:481–491.
  24. Paylor R, Crawley JN: Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology (Berl) 1997;132:169–180.
  25. Dulawa SC, Geyer MA: Psychopharmacology of prepulse inhibition in mice. Chin J Physiol 1996;39:139–146.
  26. Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J, Crawley JN: Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 2004;3:287–302.
  27. Moy SS, Nadler JJ, Young NB, Perez A, Holloway LP, Barbaro RP, Barbaro JR, Wilson LM, Threadgill DW, Lauder JM, Magnuson TR, Crawley JN: Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res 2007;176:4–20.
  28. Nadler JJ, Moy SS, Dold G, Trang D, Simmons N, Perez A, Young NB, Barbaro RP, Piven J, Magnuson TR, Crawley JN: Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav 2004;3:303–314.
  29. Duncan GE, Moy SS, Lieberman JA, Koller BH: Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function. Psychopharmacology (Berl) 2006;184:190–200.
  30. Fairless AH, Shah RY, Guthrie AJ, Li H, Brodkin ES: Deconstructing sociability, an autism-relevant phenotype, in mouse models. Anat Rec (Hoboken) 2011;294:1713–1725.

    External Resources

  31. Huggenberger HJ, Suter SE, Blumenthal TD, Schachinger H: Pre- and perinatal predictors of startle eye blink reaction and prepulse inhibition in healthy neonates. Psychophysiology 2011;48:1004–1010.

    External Resources

  32. Anday EK, Cohen ME, Kelley NE, Hoffman HS: Reflex modification audiometry: assessment of acoustic sensory processing in the term neonate. Pediatr Res 1988;23:357–363.
  33. Ornitz EM, Guthrie D, Sadeghpour M, Sugiyama T: Maturation of prestimulation-induced startle modulation in girls. Psychophysiology 1991;28:11–20.
  34. Hoffman HS, Cohen ME, English LM: Reflex modification by acoustic signals in newborn infants and in adults. J Exp Child Psychol 1985;39:562–579.
  35. Castle D, Sham P, Murray R: Differences in distribution of ages of onset in males and females with schizophrenia. Schizophr Res 1998;33:179–183.
  36. Leung A, Chue P: Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 2000;401:3–38.
  37. Abel KM, Drake R, Goldstein JM: Sex differences in schizophrenia. Int Rev Psychiatry 2010;22:417–428.

    External Resources

  38. Labrie V, Lipina T, Roder JC: Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia. Psychopharmacology (Berl) 2008;200:217–230.
  39. Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, Gallop RJ, Arnold SE: Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 2006;12:824–828.
  40. Moy SS, Troy Ghashghaei H, Nonneman RJ, Weimer JM, Yokota Y, Lee D, Lai C, Threadgill DW, Anton ES: Deficient NRG1-ERBB signaling alters social approach: relevance to genetic mouse models of schizophrenia. J Neurodev Disord 2009;1:302–312.

    External Resources

  41. Feyder M, Karlsson RM, Mathur P, Lyman M, Bock R, Momenan R, Munasinghe J, Scattoni ML, Ihne J, Camp M, Graybeal C, Strathdee D, Begg A, Alvarez VA, Kirsch P, Rietschel M, Cichon S, Walter H, Meyer-Lindenberg A, Grant SG, Holmes A: Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams’ syndrome. Am J Psychiatry 2010;167:1508–1517.

    External Resources

  42. Schaevitz LR, Moriuchi JM, Nag N, Mellot TJ, Berger-Sweeney J: Cognitive and social functions and growth factors in a mouse model of Rett syndrome. Physiol Behav 2010;100:255–263.
  43. Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, Neul JL, Gong S, Lu HC, Heintz N, Ekker M, Rubenstein JL, Noebels JL, Rosenmund C, Zoghbi HY: Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010;468:263–269.
  44. Blue ME, Kaufmann WE, Bressler J, Eyring C, O’Driscoll C, Naidu S, Johnston MV: Temporal and regional alterations in NMDA receptor expression in Mecp2-null mice. Anat Rec (Hoboken) 2011;294:1624–1634.
  45. Belforte JE, Zsiros V, Sklar ER, Jiang Z, Yu G, Li Y, Quinlan EM, Nakazawa K: Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci 2010;13:76–83.
  46. Clapcote SJ, Lipina TV, Millar JK, Mackie S, Christie S, Ogawa F, Lerch JP, Trimble K, Uchiyama M, Sakuraba Y, Kaneda H, Shiroishi T, Houslay MD, Henkelman RM, Sled JG, Gondo Y, Porteous DJ, Roder JC: Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 2007;54:387–402.
  47. Hikida T, Jaaro-Peled H, Seshadri S, Oishi K, Hookway C, Kong S, Wu D, Xue R, Andrade M, Tankou S, Mori S, Gallagher M, Ishizuka K, Pletnikov M, Kida S, Sawa A: Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci USA 2007;104:14501–14506.
  48. Pletnikov MV, Ayhan Y, Nikolskaia O, Xu Y, Ovanesov MV, Huang H, Mori S, Moran TH, Ross CA: Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry 2008;13:173–186, 115.
  49. Spear LP: The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 2000;24:417–463.
  50. Hayashi-Takagi A, Barker PB, Sawa A: Readdressing synaptic pruning theory for schizophrenia: combination of brain imaging and cell biology. Commun Integr Biol 2011;4:211–212.

    External Resources

  51. Faludi G, Mirnics K: Synaptic changes in the brain of subjects with schizophrenia. Int J Dev Neurosci 2011;29:305–309.

    External Resources

  52. Hoffman RE, Dobscha SK: Cortical pruning and the development of schizophrenia: a computer model. Schizophr Bull 1989;15:477–490.
  53. Mirnics K, Middleton FA, Lewis DA, Levitt P: Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci 2001;24:479–486.
  54. Alvarez VA, Ridenour DA, Sabatini BL: Distinct structural and ionotropic roles of NMDA receptors in controlling spine and synapse stability. J Neurosci 2007;27:7365–7376.
  55. Hayashi-Takagi A, Takaki M, Graziane N, Seshadri S, Murdoch H, Dunlop AJ, Makino Y, Seshadri AJ, Ishizuka K, Srivastava DP, Xie Z, Baraban JM, Houslay MD, Tomoda T, Brandon NJ, Kamiya A, Yan Z, Penzes P, Sawa A: Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat Neurosci 2010;13:327–332.
  56. Veenema AH, Bredewold R, Neumann ID: Opposite effects of maternal separation on intermale and maternal aggression in C57BL/6 mice: link to hypothalamic vasopressin and oxytocin immunoreactivity. Psychoneuroendocrinology 2007;32:437–450.
  57. Romeo RD, Mueller A, Sisti HM, Ogawa S, McEwen BS, Brake WG: Anxiety and fear behaviors in adult male and female C57BL/6 mice are modulated by maternal separation. Horm Behav 2003;43:561–567.
  58. Wang L, Jiao J, Dulawa SC: Infant maternal separation impairs adult cognitive performance in BALB/cJ mice. Psychopharmacology (Berl) 2011;216:207–218.
  59. Binder E, Malki K, Paya-Cano JL, Fernandes C, Aitchison KJ, Mathe AA, Sluyter F, Schalkwyk LC: Antidepressants and the resilience to early-life stress in inbred mouse strains. Pharmacogenet Genomics 2011;21:779–789.
  60. Mehta M, Schmauss C: Strain-specific cognitive deficits in adult mice exposed to early life stress. Behav Neurosci 2011;125:29–36.

    External Resources

  61. Millstein RA, Holmes A: Effects of repeated maternal separation on anxiety- and depression-related phenotypes in different mouse strains. Neurosci Biobehav Rev 2007;31:3–17.
  62. Millstein RA, Ralph RJ, Yang RJ, Holmes A: Effects of repeated maternal separation on prepulse inhibition of startle across inbred mouse strains. Genes Brain Behav 2006;5:346–354.
  63. Thompson JL, Pogue-Geile MF, Grace AA: Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms. Schizophr Bull 2004;30:875–900.

    External Resources

  64. Walker E, Mittal V, Tessner K: Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol 2008;4:189–216.
  65. Weinberger DR: Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987;44:660–669.
  66. Lieberman JA: Neuroprotection: a new strategy in the treatment of schizophrenia. Neurobiological basis of neurodegeneration and neuroprotection. CNS Spectr 2007;12(10 suppl 18):4–6.
  67. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M: Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 2005;62:361–370.
  68. Salimi K, Jarskog LF, Lieberman JA: Antipsychotic drugs for first-episode schizophrenia: a comparative review. CNS Drugs 2009;23:837–855.
  69. Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG: Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev 2008;60:358–403.
  70. Done DJ, Crow TJ, Johnstone EC, Sacker A: Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ 1994;309:699–703.
  71. Welham J, Isohanni M, Jones P, McGrath J: The antecedents of schizophrenia: a review of birth cohort studies. Schizophr Bull 2009;35:603–623.

    External Resources

  72. Larson MK, Walker EF, Compton MT: Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders. Expert Rev Neurother 2010;10:1347–1359.

    External Resources

  

Author Contacts

Sheryl S. Moy, PhD
Carolina Institute for Developmental Disabilities, CB#7146
University of North Carolina School of Medicine
Chapel Hill, NC 27599 (USA)
Tel. +1 919 966 3082, E-Mail ssmoy@med.unc.edu

  

Article Information

Received: November 9, 2011
Accepted after revision: March 8, 2012
Published online: May 8, 2012
Number of Print Pages : 15
Number of Figures : 11, Number of Tables : 0, Number of References : 72

  

Publication Details

Developmental Neuroscience

Vol. 34, No. 2-3, Year 2012 (Cover Date: September 2012)

Journal Editor: Levison S.W. (Newark, N.J.)
ISSN: 0378-5866 (Print), eISSN: 1421-9859 (Online)

For additional information: http://www.karger.com/DNE


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Abstract

Mice with knockdown of the N-methyl-d-aspartate (NMDA) receptor NR1 subunit, encoded by the gene Grin1, have been investigated as a model for the intrinsic NMDA hypofunction hypothesized for schizophrenia. Previous work has shown that adult Grin1 mutant mice have overt deficits in habituation and sensorimotor gating, exaggerated reactivity to environmental stimuli, reduced social approach, and other alterations that reflect behavioral manifestations of schizophrenia. In humans, the emergence of overt symptoms of the disorder typically occurs in adolescence or early adulthood, suggesting a role for aberrant maturation of NMDA receptor signaling in symptom onset. The following study evaluated Grin1 mutant mice for abnormal behavioral phenotypes during the preweaning, adolescent, and adult periods. Measures included open field activity, prepulse inhibition of acoustic startle responses, and social preference in a three-chamber choice task. Mice from the C57BL/6J inbred strain, one of the parental strains for the Grin1 line, were also tested. The results showed that developmental reduction of NMDA receptor function led to significant alterations in behavior during the second and third weeks of life, including exaggerated startle responses and sensorimotor gating deficits on postnatal day 13, and pronounced hypersociability in adolescence. Male Grin1 mutant mice were more susceptible than female mice to the detrimental effects of decreased NMDA signaling. Overall, these findings provide evidence that reduced Grin1 function leads to abnormal phenotypes in the preweaning period, and that deficient NMDA signaling can lead to both overt hypersociability or marked asociality, dependent upon sex and age.

© 2012 S. Karger AG, Basel


  

Author Contacts

Sheryl S. Moy, PhD
Carolina Institute for Developmental Disabilities, CB#7146
University of North Carolina School of Medicine
Chapel Hill, NC 27599 (USA)
Tel. +1 919 966 3082, E-Mail ssmoy@med.unc.edu

  

Article Information

Received: November 9, 2011
Accepted after revision: March 8, 2012
Published online: May 8, 2012
Number of Print Pages : 15
Number of Figures : 11, Number of Tables : 0, Number of References : 72

  

Publication Details

Developmental Neuroscience

Vol. 34, No. 2-3, Year 2012 (Cover Date: September 2012)

Journal Editor: Levison S.W. (Newark, N.J.)
ISSN: 0378-5866 (Print), eISSN: 1421-9859 (Online)

For additional information: http://www.karger.com/DNE


Article / Publication Details

First-Page Preview
Abstract of Paper

Received: 11/9/2011 9:23:33 AM
Accepted: 3/8/2012
Published online: 5/8/2012
Issue release date: September 2012

Number of Print Pages: 15
Number of Figures: 11
Number of Tables: 0

ISSN: 0378-5866 (Print)
eISSN: 1421-9859 (Online)

For additional information: http://www.karger.com/DNE


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Coyle JT: Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 2006;26:365–384.
  2. Jentsch JD, Roth RH: The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1999;20:201–225.
  3. Kim JS, Kornhuber HH, Schmid-Burgk W, Holzmuller B: Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 1980;20:379–382.
  4. Moghaddam B: Recent basic findings in support of excitatory amino acid hypotheses of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:859–870.
  5. Olney JW, Farber NB: Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995;52:998–1007.
  6. Marshall BE, Longnecker DE: General anesthetics; in Gilman AG, Rall TW, Nies AS, Taylor P (eds): Goodman and Gilman’s The Pharmacological Basis of Therapeutics. New York, Pergamon Press, 1990.
  7. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders DSM-IV TR (Text Revision). Arlington, American Psychiatric Association, 2000.
  8. Duncan GE, Moy SS, Perez A, Eddy DM, Zinzow WM, Lieberman JA, Snouwaert JN, Koller BH: Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behav Brain Res 2004;153:507–519.
  9. Halene TB, Ehrlichman RS, Liang Y, Christian EP, Jonak GJ, Gur TL, Blendy JA, Dow HC, Brodkin ES, Schneider F, Gur RC, Siegel SJ: Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia. Genes Brain Behav 2009;8:661–675.
  10. Mohn AR, Gainetdinov RR, Caron MG, Koller BH: Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 1999;98:427–436.
  11. Ramsey AJ: NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia. Prog Brain Res 2009;179:51–58.
  12. Fradley RL, O’Meara GF, Newman RJ, Andrieux A, Job D, Reynolds DS: STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating. Behav Brain Res 2005;163:257–264.
  13. Moy SS, Perez A, Koller BH, Duncan GE: Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function. Brain Res 2006;1089:186–194.
  14. Moy SS, Nadler JJ, Poe MD, Nonneman RJ, Young NB, Koller BH, Crawley JN, Duncan GE, Bodfish JW: Development of a mouse test for repetitive, restricted behaviors: relevance to autism. Behav Brain Res 2008;188:178–194.
  15. Duncan GE, Inada K, Farrington JS, Koller BH, Moy SS: Neural activation deficits in a mouse genetic model of NMDA receptor hypofunction in tests of social aggression and swim stress. Brain Res 2009;1265:186–195.
  16. Ramsey AJ, Milenkovic M, Oliveira AF, Escobedo-Lozoya Y, Seshadri S, Salahpour A, Sawa A, Yasuda R, Caron MG: Impaired NMDA receptor transmission alters striatal synapses and DISC1 protein in an age-dependent manner. Proc Natl Acad Sci USA 2011;108:5795–5800.
  17. Nakamura K, Koyama Y, Takahashi K, Tsurui H, Xiu Y, Ohtsuji M, Lin QS, Sugawara Y, Sawabe K, Ohashi A, Ohnuma T, Arai H, Nishimura H, Hasegawa H, Hirose S: Requirement of tryptophan hydroxylase during development for maturation of sensorimotor gating. J Mol Biol 2006;363:345–354.
  18. Yun SW, Platholi J, Flaherty MS, Fu W, Kottmann AH, Toth M: Fmrp is required for the establishment of the startle response during the critical period of auditory development. Brain Res 2006;1110:159–165.
  19. Bignami G, Alleva E, Chiarotti F, Laviola G: Selective changes in mouse behavioral development after prenatal benzodiazepine exposure: a progress report. Prog Neuropsychopharmacol Biol Psychiatry 1992;16:587–604.
  20. Shnerson A, Willott JF: Ontogeny of the acoustic startle response in C57BL/6J mouse pups. J Comp Physiol Psychol 1980;94:36–40.
  21. Tremml P, Lipp HP, Muller U, Ricceri L, Wolfer DP: Neurobehavioral development, adult openfield exploration and swimming navigation learning in mice with a modified beta-amyloid precursor protein gene. Behav Brain Res 1998;95:65–76.
  22. Ryan BC, Young NB, Crawley JN, Bodfish JW, Moy SS: Social deficits, stereotypy and early emergence of repetitive behavior in the C58/J inbred mouse strain. Behav Brain Res 2010;208:178–188.
  23. Duncan GE, Moy SS, Lieberman JA, Koller BH: Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction. Pharmacol Biochem Behav 2006;85:481–491.
  24. Paylor R, Crawley JN: Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology (Berl) 1997;132:169–180.
  25. Dulawa SC, Geyer MA: Psychopharmacology of prepulse inhibition in mice. Chin J Physiol 1996;39:139–146.
  26. Moy SS, Nadler JJ, Perez A, Barbaro RP, Johns JM, Magnuson TR, Piven J, Crawley JN: Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 2004;3:287–302.
  27. Moy SS, Nadler JJ, Young NB, Perez A, Holloway LP, Barbaro RP, Barbaro JR, Wilson LM, Threadgill DW, Lauder JM, Magnuson TR, Crawley JN: Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res 2007;176:4–20.
  28. Nadler JJ, Moy SS, Dold G, Trang D, Simmons N, Perez A, Young NB, Barbaro RP, Piven J, Magnuson TR, Crawley JN: Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav 2004;3:303–314.
  29. Duncan GE, Moy SS, Lieberman JA, Koller BH: Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function. Psychopharmacology (Berl) 2006;184:190–200.
  30. Fairless AH, Shah RY, Guthrie AJ, Li H, Brodkin ES: Deconstructing sociability, an autism-relevant phenotype, in mouse models. Anat Rec (Hoboken) 2011;294:1713–1725.

    External Resources

  31. Huggenberger HJ, Suter SE, Blumenthal TD, Schachinger H: Pre- and perinatal predictors of startle eye blink reaction and prepulse inhibition in healthy neonates. Psychophysiology 2011;48:1004–1010.

    External Resources

  32. Anday EK, Cohen ME, Kelley NE, Hoffman HS: Reflex modification audiometry: assessment of acoustic sensory processing in the term neonate. Pediatr Res 1988;23:357–363.
  33. Ornitz EM, Guthrie D, Sadeghpour M, Sugiyama T: Maturation of prestimulation-induced startle modulation in girls. Psychophysiology 1991;28:11–20.
  34. Hoffman HS, Cohen ME, English LM: Reflex modification by acoustic signals in newborn infants and in adults. J Exp Child Psychol 1985;39:562–579.
  35. Castle D, Sham P, Murray R: Differences in distribution of ages of onset in males and females with schizophrenia. Schizophr Res 1998;33:179–183.
  36. Leung A, Chue P: Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 2000;401:3–38.
  37. Abel KM, Drake R, Goldstein JM: Sex differences in schizophrenia. Int Rev Psychiatry 2010;22:417–428.

    External Resources

  38. Labrie V, Lipina T, Roder JC: Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia. Psychopharmacology (Berl) 2008;200:217–230.
  39. Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH, Bakshi K, Kamins J, Borgmann-Winter KE, Siegel SJ, Gallop RJ, Arnold SE: Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 2006;12:824–828.
  40. Moy SS, Troy Ghashghaei H, Nonneman RJ, Weimer JM, Yokota Y, Lee D, Lai C, Threadgill DW, Anton ES: Deficient NRG1-ERBB signaling alters social approach: relevance to genetic mouse models of schizophrenia. J Neurodev Disord 2009;1:302–312.

    External Resources

  41. Feyder M, Karlsson RM, Mathur P, Lyman M, Bock R, Momenan R, Munasinghe J, Scattoni ML, Ihne J, Camp M, Graybeal C, Strathdee D, Begg A, Alvarez VA, Kirsch P, Rietschel M, Cichon S, Walter H, Meyer-Lindenberg A, Grant SG, Holmes A: Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams’ syndrome. Am J Psychiatry 2010;167:1508–1517.

    External Resources

  42. Schaevitz LR, Moriuchi JM, Nag N, Mellot TJ, Berger-Sweeney J: Cognitive and social functions and growth factors in a mouse model of Rett syndrome. Physiol Behav 2010;100:255–263.
  43. Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, Neul JL, Gong S, Lu HC, Heintz N, Ekker M, Rubenstein JL, Noebels JL, Rosenmund C, Zoghbi HY: Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010;468:263–269.
  44. Blue ME, Kaufmann WE, Bressler J, Eyring C, O’Driscoll C, Naidu S, Johnston MV: Temporal and regional alterations in NMDA receptor expression in Mecp2-null mice. Anat Rec (Hoboken) 2011;294:1624–1634.
  45. Belforte JE, Zsiros V, Sklar ER, Jiang Z, Yu G, Li Y, Quinlan EM, Nakazawa K: Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci 2010;13:76–83.
  46. Clapcote SJ, Lipina TV, Millar JK, Mackie S, Christie S, Ogawa F, Lerch JP, Trimble K, Uchiyama M, Sakuraba Y, Kaneda H, Shiroishi T, Houslay MD, Henkelman RM, Sled JG, Gondo Y, Porteous DJ, Roder JC: Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 2007;54:387–402.
  47. Hikida T, Jaaro-Peled H, Seshadri S, Oishi K, Hookway C, Kong S, Wu D, Xue R, Andrade M, Tankou S, Mori S, Gallagher M, Ishizuka K, Pletnikov M, Kida S, Sawa A: Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc Natl Acad Sci USA 2007;104:14501–14506.
  48. Pletnikov MV, Ayhan Y, Nikolskaia O, Xu Y, Ovanesov MV, Huang H, Mori S, Moran TH, Ross CA: Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry 2008;13:173–186, 115.
  49. Spear LP: The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 2000;24:417–463.
  50. Hayashi-Takagi A, Barker PB, Sawa A: Readdressing synaptic pruning theory for schizophrenia: combination of brain imaging and cell biology. Commun Integr Biol 2011;4:211–212.

    External Resources

  51. Faludi G, Mirnics K: Synaptic changes in the brain of subjects with schizophrenia. Int J Dev Neurosci 2011;29:305–309.

    External Resources

  52. Hoffman RE, Dobscha SK: Cortical pruning and the development of schizophrenia: a computer model. Schizophr Bull 1989;15:477–490.
  53. Mirnics K, Middleton FA, Lewis DA, Levitt P: Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci 2001;24:479–486.
  54. Alvarez VA, Ridenour DA, Sabatini BL: Distinct structural and ionotropic roles of NMDA receptors in controlling spine and synapse stability. J Neurosci 2007;27:7365–7376.
  55. Hayashi-Takagi A, Takaki M, Graziane N, Seshadri S, Murdoch H, Dunlop AJ, Makino Y, Seshadri AJ, Ishizuka K, Srivastava DP, Xie Z, Baraban JM, Houslay MD, Tomoda T, Brandon NJ, Kamiya A, Yan Z, Penzes P, Sawa A: Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat Neurosci 2010;13:327–332.
  56. Veenema AH, Bredewold R, Neumann ID: Opposite effects of maternal separation on intermale and maternal aggression in C57BL/6 mice: link to hypothalamic vasopressin and oxytocin immunoreactivity. Psychoneuroendocrinology 2007;32:437–450.
  57. Romeo RD, Mueller A, Sisti HM, Ogawa S, McEwen BS, Brake WG: Anxiety and fear behaviors in adult male and female C57BL/6 mice are modulated by maternal separation. Horm Behav 2003;43:561–567.
  58. Wang L, Jiao J, Dulawa SC: Infant maternal separation impairs adult cognitive performance in BALB/cJ mice. Psychopharmacology (Berl) 2011;216:207–218.
  59. Binder E, Malki K, Paya-Cano JL, Fernandes C, Aitchison KJ, Mathe AA, Sluyter F, Schalkwyk LC: Antidepressants and the resilience to early-life stress in inbred mouse strains. Pharmacogenet Genomics 2011;21:779–789.
  60. Mehta M, Schmauss C: Strain-specific cognitive deficits in adult mice exposed to early life stress. Behav Neurosci 2011;125:29–36.

    External Resources

  61. Millstein RA, Holmes A: Effects of repeated maternal separation on anxiety- and depression-related phenotypes in different mouse strains. Neurosci Biobehav Rev 2007;31:3–17.
  62. Millstein RA, Ralph RJ, Yang RJ, Holmes A: Effects of repeated maternal separation on prepulse inhibition of startle across inbred mouse strains. Genes Brain Behav 2006;5:346–354.
  63. Thompson JL, Pogue-Geile MF, Grace AA: Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms. Schizophr Bull 2004;30:875–900.

    External Resources

  64. Walker E, Mittal V, Tessner K: Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia. Annu Rev Clin Psychol 2008;4:189–216.
  65. Weinberger DR: Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987;44:660–669.
  66. Lieberman JA: Neuroprotection: a new strategy in the treatment of schizophrenia. Neurobiological basis of neurodegeneration and neuroprotection. CNS Spectr 2007;12(10 suppl 18):4–6.
  67. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, Keefe RS, Green AI, Gur RE, McEvoy J, Perkins D, Hamer RM, Gu H, Tohen M: Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 2005;62:361–370.
  68. Salimi K, Jarskog LF, Lieberman JA: Antipsychotic drugs for first-episode schizophrenia: a comparative review. CNS Drugs 2009;23:837–855.
  69. Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG: Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev 2008;60:358–403.
  70. Done DJ, Crow TJ, Johnstone EC, Sacker A: Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ 1994;309:699–703.
  71. Welham J, Isohanni M, Jones P, McGrath J: The antecedents of schizophrenia: a review of birth cohort studies. Schizophr Bull 2009;35:603–623.

    External Resources

  72. Larson MK, Walker EF, Compton MT: Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders. Expert Rev Neurother 2010;10:1347–1359.

    External Resources